Literature DB >> 11755399

Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory activity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition.

T Usui1, S Kojima, S Kidokoro, K Ueda, H Osada, M Sodeoka.   

Abstract

BACKGROUND: VHR is a dual-specificity phosphatase, which dephosphorylates activated ERK1/2 and weakens the ERK signaling cascade in mammalian cells. A selective inhibitor is expected to be useful for revealing the physiological function of VHR.
RESULTS: First, we investigated the molecular mechanism of VHR inhibition by a known natural product, RK-682. Kinetic analysis indicated that inhibition was competitive toward the substrate, and two molecules of RK-682 were required to inhibit one molecule of VHR. Based on the structure-activity relationships for VHR inhibition by RK-682 derivatives, we constructed a binding model using molecular dynamics calculation. Based on this model, we designed and synthesized a novel dimeric derivative. As expected, the dimeric derivative showed increased inhibition of VHR, supporting our proposed mechanism of VHR inhibition by RK-682.
CONCLUSION: We have developed a novel inhibitor of VHR based on the results of kinetic analysis and docking simulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11755399     DOI: 10.1016/s1074-5521(01)00089-8

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  5 in total

1.  F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414.

Authors:  Yuki Hirota-Takahata; Yoko Ishimoto; Emi Kurosawa; Yuko Iwadate; Yoshiko Onozawa; Isshin Tanaka; Masahiro Tanaka; Hideki Kobayashi
Journal:  J Antibiot (Tokyo)       Date:  2017-08-09       Impact factor: 2.649

2.  Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.

Authors:  Ekaterina V Bobkova; Wallace H Liu; Sharon Colayco; Justin Rascon; Stefan Vasile; Carlton Gasior; David A Critton; Xochella Chan; Russell Dahl; Ying Su; Eduard Sergienko; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Lutz Tautz
Journal:  ACS Med Chem Lett       Date:  2011-02       Impact factor: 4.345

3.  Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.

Authors:  Lucia Musumeci; Marijke J Kuijpers; Karen Gilio; Alexandre Hego; Emilie Théâtre; Lisbeth Maurissen; Maud Vandereyken; Catia V Diogo; Christelle Lecut; William Guilmain; Ekaterina V Bobkova; Johannes A Eble; Russell Dahl; Pierre Drion; Justin Rascon; Yalda Mostofi; Hongbin Yuan; Eduard Sergienko; Thomas D Y Chung; Marc Thiry; Yotis Senis; Michel Moutschen; Tomas Mustelin; Patrizio Lancellotti; Johan W M Heemskerk; Lutz Tautz; Cécile Oury; Souad Rahmouni
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

Review 4.  Structure-Activity Relationship of Cytotoxic Natural Products from Indonesian Marine Sponges.

Authors:  Jonathan A Panggabean; Sya'ban P Adiguna; Tutik Murniasih; Siti I Rahmawati; Asep Bayu; Masteria Y Putra
Journal:  Rev Bras Farmacogn       Date:  2022-01-07       Impact factor: 2.464

5.  Spatiotemporal regulation of ERK2 by dual specificity phosphatases.

Authors:  Christopher J Caunt; Stephen P Armstrong; Caroline A Rivers; Michael R Norman; Craig A McArdle
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.